Trial Profile
Assessment of bleeding in patients with disseminated intravascular coagulation after surgical treatment receiving recombinant human soluble thrombomodulin: A cohort study using DPC database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation
- Focus Adverse reactions
- 09 Dec 2018 Status changed from active, no longer recruiting to completed.
- 25 Jan 2018 New trial record